Literature DB >> 27096261

Should hypoxia preconditioning become the standardized procedure for bone marrow MSCs preparation for clinical use?

Yong-Can Huang1, Ornella Parolini2, Li Deng3, Bin-Sheng Yu1,4.   

Abstract

Entities:  

Keywords:  Bone marrow; Genomics; Hypoxia; Mesenchymal stem cells

Mesh：

Year:  2016        PMID： 27096261     DOI： 10.1002/stem.2389

Source DB:  PubMed          Journal:  Stem Cells        ISSN： 1066-5099            Impact factor:   6.277


× No keyword cloud information.
  9 in total

1.  The influence of hypoxia and IFN-γ on the proteome and metabolome of therapeutic mesenchymal stem cells.

Authors:  Holly M Wobma; Manuel A Tamargo; Shahar Goeta; Lewis M Brown; Raimon Duran-Struuck; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2018-03-15       Impact factor: 12.479

2.  Dual IFN-γ/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms.

Authors:  Holly M Wobma; Mariko Kanai; Stephen P Ma; Ying Shih; Hao Wei Li; Raimon Duran-Struuck; Robert Winchester; Shahar Goeta; Lewis M Brown; Gordana Vunjak-Novakovic
Journal:  J Immunol Regen Med       Date:  2018-04-25

3.  The Expression of HMGB1 in Bone Marrow MSCs Is Upregulated by Hypoxia with Regulatory Effects on the Apoptosis and Adhesion.

Authors:  Mei-Yun Tan; Cai-Dong Zhang; Bo Xia; Jiang Guo; Zhong-Wei Fan; Tian-Hao Wu; Sen Wang; Shao-Feng Liu; Li Deng; Xing Guo; Yong-Can Huang
Journal:  Biomed Res Int       Date:  2016-12-06       Impact factor: 3.411

4.  Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis.

Authors:  Jun Hee Lee; Yeo Min Yoon; Sang Hun Lee
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

Review 5.  Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecast.

Authors:  Andrea De Pieri; Yury Rochev; Dimitrios I Zeugolis
Journal:  NPJ Regen Med       Date:  2021-03-29

6.  Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells.

Authors:  Victor G Martinez; Imelda Ontoria-Oviedo; Carolina P Ricardo; Sian E Harding; Rosa Sacedon; Alberto Varas; Agustin Zapata; Pilar Sepulveda; Angeles Vicente
Journal:  Stem Cell Res Ther       Date:  2017-09-29       Impact factor: 6.832

7.  Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells.

Authors:  Ben Antebi; Luis A Rodriguez; Kerfoot P Walker; Amber M Asher; Robin M Kamucheka; Lucero Alvarado; Arezoo Mohammadipoor; Leopoldo C Cancio
Journal:  Stem Cell Res Ther       Date:  2018-10-11       Impact factor: 6.832

8.  Human Mesenchymal Stem Cell Secretome from Bone Marrow or Adipose-Derived Tissue Sources for Treatment of Hypoxia-Induced Pulmonary Epithelial Injury.

Authors:  Nala Shologu; Michael Scully; John G Laffey; Daniel O'Toole
Journal:  Int J Mol Sci       Date:  2018-09-30       Impact factor: 5.923

9.  Modulation of the Dental Pulp Stem Cell Secretory Profile by Hypoxia Induction Using Cobalt Chloride.

Authors:  Shilpa Bhandi; Ahmed Al Kahtani; Mohammed Mashyakhy; Loai Alsofi; Prabhadevi C Maganur; Satish Vishwanathaiah; Luca Testarelli; Andrea Del Giudice; Deepak Mehta; Nishant Vyas; Vikrant R Patil; A Thirumal Raj; Shankargouda Patil
Journal:  J Pers Med       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.